John Newman
Stock Analyst at Canaccord Genuity
(1.31)
# 2,520
Out of 4,414 analysts
37
Total ratings
39.53%
Success rate
-14.78%
Average return
Main Sectors:
Top Industries:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACET Adicet Bio | Reiterates: Buy | $19 | $1.41 | +1,247.52% | 2 | Mar 20, 2024 | |
| ACLX Arcellx | Maintains: Buy | $66 → $85 | $53.29 | +59.50% | 5 | Feb 29, 2024 | |
| REGN Regeneron Pharmaceuticals | Upgrades: Buy | $720 → $992 | $937.61 | +5.80% | 10 | Aug 21, 2023 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $1.17 | +327.35% | 2 | Jun 23, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $35 | $2.97 | +1,078.45% | 1 | Jun 16, 2023 | |
| ATRA Atara Biotherapeutics | Maintains: Buy | $50 → $20 | $0.65 | +2,975.50% | 1 | May 9, 2023 | |
| MCRB Seres Therapeutics | Maintains: Buy | $11 → $15 | $1.11 | +1,251.35% | 3 | Mar 21, 2023 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $52 → $44 | $34.58 | +27.24% | 1 | Feb 16, 2022 | |
| BLUE bluebird bio | Downgrades: Hold | n/a | $0.90 | - | 3 | Aug 10, 2021 | |
| ALRN Aileron Therapeutics | Maintains: Buy | n/a | $3.82 | - | 2 | Apr 9, 2019 | |
| SAGE Sage Therapeutics | Maintains: Buy | n/a | $13.11 | - | 3 | Jun 13, 2018 | |
| VBIV VBI Vaccines | Initiates: Buy | n/a | $0.58 | - | 1 | Nov 1, 2017 | |
| HCM HUTCHMED (China) | Maintains: Buy | n/a | $19.56 | - | 1 | Oct 17, 2017 | |
| ALDX Aldeyra Therapeutics | Maintains: Buy | n/a | $4.21 | - | 1 | Sep 13, 2017 | |
| AUPH Aurinia Pharmaceuticals | Downgrades: Speculative Buy | n/a | $5.17 | - | 1 | Sep 13, 2017 |
Adicet Bio
Mar 20, 2024
Reiterates: Buy
Price Target: $19
Current: $1.41
Upside: +1,247.52%
Arcellx
Feb 29, 2024
Maintains: Buy
Price Target: $66 → $85
Current: $53.29
Upside: +59.50%
Regeneron Pharmaceuticals
Aug 21, 2023
Upgrades: Buy
Price Target: $720 → $992
Current: $937.61
Upside: +5.80%
Oncolytics Biotech
Jun 23, 2023
Reiterates: Buy
Price Target: $5
Current: $1.17
Upside: +327.35%
Allogene Therapeutics
Jun 16, 2023
Reiterates: Buy
Price Target: $35
Current: $2.97
Upside: +1,078.45%
Atara Biotherapeutics
May 9, 2023
Maintains: Buy
Price Target: $50 → $20
Current: $0.65
Upside: +2,975.50%
Seres Therapeutics
Mar 21, 2023
Maintains: Buy
Price Target: $11 → $15
Current: $1.11
Upside: +1,251.35%
Agios Pharmaceuticals
Feb 16, 2022
Maintains: Buy
Price Target: $52 → $44
Current: $34.58
Upside: +27.24%
bluebird bio
Aug 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.90
Upside: -
Aileron Therapeutics
Apr 9, 2019
Maintains: Buy
Price Target: n/a
Current: $3.82
Upside: -
Sage Therapeutics
Jun 13, 2018
Maintains: Buy
Price Target: n/a
Current: $13.11
Upside: -
VBI Vaccines
Nov 1, 2017
Initiates: Buy
Price Target: n/a
Current: $0.58
Upside: -
HUTCHMED (China)
Oct 17, 2017
Maintains: Buy
Price Target: n/a
Current: $19.56
Upside: -
Aldeyra Therapeutics
Sep 13, 2017
Maintains: Buy
Price Target: n/a
Current: $4.21
Upside: -
Aurinia Pharmaceuticals
Sep 13, 2017
Downgrades: Speculative Buy
Price Target: n/a
Current: $5.17
Upside: -